Macoven Pharmaceuticals Accused Of Patent Infringement

Magnolia-based Macoven Pharmaceuticals has been accused of intellectual property violations in a complaint filed with the U.S. International Trade Commission.

Pamlab, Merck & Cie, and the South Alabama Medical Science Foundation allege Macoven imported drugs from Italy that infringe on the plaintiffs’ patents. The class of drugs, known as reduced folates, is prescribed to treat high-risk pregnancy, dementia, and depression, among other medical conditions.

Jamie Underwood, a partner with the law firm of Alston & Bird, is an attorney for the complainants.

“Money damages are not available at the ITC. Instead what you get is a type of injunction or an exclusion order, typically, so that any infringing products are not coming into the U.S. market.”

This is the third legal action the complainants have taken against Macoven in the past year. The first two were law suits filed in federal courts in Texas and New York.

Calls to Macoven requesting comment for this story were not returned.

Bio photo of Andrew Schneider

Andrew Schneider

Business Reporter

Andrew Schneider joined KUHF in January 2011, after more than a decade as a print reporter for The Kiplinger Letter...